BOC Sciences offers comprehensive one-stop antibody-drug conjugate research and evaluation services.
BOC Sciences provides customers with comprehensive one-stop services for all aspects of antibody-drug conjugate research and evaluation, from antibody modification and conjugation, cytotoxin development, cytotoxin-linker synthesis, ADC manufacturing, to ADC characterization and evaluation various stages.
Feb 27. 2024
At present, a variety of new conjugation technology concepts have emerged, including peptide drug conjugates (PDC), small molecule drug conjugates (SMDC), immunostimulatory antibody conjugates (ISAC), antibody-oligonucleotides conjugates (AOC), radionuclide drug conjugates (RDC), etc.
Jan 5. 2024
Neutralizing antibody (NAb) is a special kind of ADA. NAbs interfere with the in vivo activity of drugs by blocking the product from reaching its target or interfering with receptor/ligand binding. Therefore, NAbs, as a subset of antidrug antibodies, form an important part of immunogenicity research and evaluation.